Filing Details
- Accession Number:
- 0001021561-20-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-25 18:29:43
- Reporting Period:
- 2020-09-24
- Accepted Time:
- 2020-09-25 18:29:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1021561 | Nu Skin Enterprises Inc. | NUS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 870565309 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652984 | S Ryan Napierski | C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2020-09-24 | 7,000 | $30.63 | 93,500 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2020-09-24 | 10,000 | $30.63 | 103,500 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-09-24 | 22,000 | $51.18 | 81,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-09-24 | 7,000 | $0.00 | 7,000 | $30.63 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-09-24 | 10,000 | $0.00 | 10,000 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 98,800 | 2023-03-02 | No | 4 | M | Direct | |
| 40,913 | 2023-03-02 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
- Currently exercisable in full.
Billionaire Hedge Funds
